DRKS00007914
Completed
未知
Immuneactivation in neurodegenerative diseases
andesnervenklinik Wagner-Jauregg0 sites48 target enrollmentMarch 25, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Unspecified dementia
- Sponsor
- andesnervenklinik Wagner-Jauregg
- Enrollment
- 48
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Criteria for Alzheimers disease (NINDS ADRDA) and mild cognitive impairment (Petersen et al).
- •age above 18, healthy controls
Exclusion Criteria
- •Psychiatric diseases (other then dementia)
- •metabolic diseases
- •Neurodegenerative diseases other then dementia
- •Vitaminsupplementation for the last 6 weeks
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Analysing neuroinflammation and neurodegeneration in amyotrophic lateral sclerosis: quantitative imaging in a clinical trialMotor neuron disease, also referred to as amyotrophic lateral sclerosisNervous System DiseasesMotor neuron diseaseISRCTN40093015CHU de Nimes50
Completed
Not Applicable
Immunogenetic, pharmacological and neurodevelopmental aspects of nosocomial sepsis and meningitis in preterm infants.blood stream infectionsepsis10004018NL-OMON39135Vrije Universiteit Medisch Centrum280
Recruiting
Not Applicable
Immune-mediated polyneuropathy/chronic inflammatory demyelinating polyneuropathy (CIDP): diagnostic, prognostic, and treatment-response markersG61Inflammatory polyneuropathyDRKS00032455Charité - Universitätsmedizin Berlin320
Completed
Not Applicable
The effects of physical exercise on the brain and the immune system in individuals with chronic pain.Whiplash Associated DisorderChronic PainMusculoskeletal - Other muscular and skeletal disordersNeurological - Other neurological disordersACTRN12619000629134The University of Queensland16
Recruiting
Not Applicable
Study to Predict Inflammation and Neurodegeneration in Primary Progressive Multiple SclerosisPPMSPrimary Progressive Multiple Sclerosis10012303NL-OMON49540Erasmus MC, Universitair Medisch Centrum Rotterdam350